Dr. Renia Malek, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 100 E California Blvd, Pasadena, CA 91105 Phone: 626-568-8838 Fax: 626-583-8838 |
Dr. Steven Rex, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 477 E Colorado Blvd, Pasadena, CA 91101 Phone: 626-796-1191 Fax: 626-796-0189 |
Dr. Christie Chan, OD Optometrist Medicare: Medicare Enrolled Practice Location: 477 E Colorado Blvd, Pasadena, CA 91101 Phone: 626-796-1191 Fax: 626-796-0189 |
See Clear Optometry A Professional Corporation Optometrist Medicare: Medicare Enrolled Practice Location: 3235 E Colorado Blvd, Suite 101, Pasadena, CA 91107 Phone: 626-765-6634 Fax: 626-765-6722 |
Dr. Araz Housepian, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 106 W Colorado Blvd, Pasadena, CA 91105 Phone: 310-486-0192 |
Vivien Chan, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 477 E Colorado Blvd, Pasadena, CA 91101 Phone: 626-796-1191 Fax: 626-798-0189 |
Jeanne Wu, OD Optometrist Medicare: Medicare Enrolled Practice Location: 477 E Colorado Blvd, Pasadena, CA 91101 Phone: 626-796-1191 Fax: 626-796-0189 |
Lawrence W Chang, OD Optometrist Medicare: Medicare Enrolled Practice Location: 477 E Colorado Blvd, Pasadena, CA 91101 Phone: 626-796-1191 Fax: 626-796-0189 |
Pasadena Eyecare Optometry Optometrist Medicare: Medicare Enrolled Practice Location: 80 N Lake Ave, Suite 102, Pasadena, CA 91101 Phone: 626-356-8088 |
Acuity Optical Optometrist Medicare: Medicare Enrolled Practice Location: 100 E California Blvd, Pasadena, CA 91105 Phone: 626-568-8838 Fax: 626-574-7188 |
Dr. Angineh Almasi, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 477 E Colorado Blvd, Pasadena, CA 91101 Phone: 626-796-1191 Fax: 626-796-0189 |
Linh T Ho, OD Optometrist Medicare: Medicare Enrolled Practice Location: 100 E California Blvd, Pasadena, CA 91105 Phone: 800-898-2020 |
Wyse Willa Optometry, Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 1368 E Walnut St, Pasadena, CA 91106 Phone: 626-796-3105 Fax: 626-796-8816 |
Christine W Chan, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1368 E Walnut St, Pasadena, CA 91106 Phone: 626-796-3105 Fax: 626-796-8816 |
Deborah Duan Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2619 E Colorado Blvd Ste 150, Pasadena, CA 91107 Phone: 626-793-4168 |
Craig Arthur Van Woerkom, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 960 E Green St, Suite 1000, Pasadena, CA 91106 Phone: 626-793-1483 Fax: 626-793-5449 |
Dr. Wendy Yvette May Shem, O.D. Optometrist - Corneal and Contact Management Medicare: Medicare Enrolled Practice Location: 1368 E Walnut St, Pasadena, CA 91106 Phone: 626-796-3105 Fax: 626-796-8816 |
Linden Optometry A Professional Corporation Optometrist Medicare: Medicare Enrolled Practice Location: 477 E Colorado Blvd, Pasadena, CA 91101 Phone: 626-796-1191 Fax: 626-796-0189 |
Richard B Morrell, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 477 E Colorado Bl, Pasadena, CA 91101 Phone: 626-796-1191 Fax: 626-796-0189 |
Laurence R Rubin, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 477 E Colorado Blvd, Pasadena, CA 91101 Phone: 626-796-1191 Fax: 626-796-0189 |
News Archive
Even when health care experiences go well, patients and their families can still suffer harm. To date, organizational efforts to reduce harm have focused primarily on physical harm, but other forms of harm are both prevalent and equally as important.
Amorfix Life Sciences, a company focused on the development of therapeutic monoclonal antibodies and diagnostics for the treatment of fatal neurodegenerative diseases and cancer, today announced its operational and financial results for the year ended March 31, 2010, as well as financial results for the fourth quarter.
Aromatase inhibitors, a type of hormone therapy used to treat advanced breast cancer in postmenopausal women, result in a small but significant increase in overall survival when compared to other hormone treatments, according to a new systematic review of studies.
Rib-X Pharmaceuticals, Inc. today announced that the Company has raised $20 million to support ongoing development of the Company's industry-leading broad spectrum antibiotics pipeline, including late-stage clinical development of delafloxacin, which is expected to enter a Phase 2b study in early 2011.
› Verified 4 days ago